We are live on !
Find out more
Daniel Devine & Co Portfolio holdings
AUM
$125M
Turnover
9.62%
1-Year Est. Return
14.12%
This Fund
S&P 500
This Quarter Est. Return
+6.12%
1 Year Est. Return
+14.12%
3 Year Est. Return
+34.19%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$138M
AUM Growth
+$7.4M
(+5.7%)
Cap. Flow
-$504K
Cap. Flow % of AUM
Cap. Flow %
-0.36%
Top 10 Holdings %
Top 10 Hldgs %
69.63%
Holding
50
New
1
Increased
1
Reduced
20
Closed
2
Avg Time Held
2.4
years
Top 10 Avg Time Held
2.1
years
Top 20 Avg Time Held
1.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$662K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$1.85M |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$155K |
| 3 |
CNBKA
Century Bancorp Inc/Mass
CNBKA
|
+$124K |
| 4 |
Johnson & Johnson
JNJ
|
+$118K |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$114K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 59.22% |
| 2 | Healthcare | 12.46% |
| 3 | Financials | 6.95% |
| 4 | Technology | 6.71% |
| 5 | Energy | 3.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
State Street SPDR S&P 500 ETF Trust
SPY
$798B
| $32.4M | 23.46% |
121,537
-440
| -0.4% | -$114K |
2014 Q4
12 quarters
|
|
2
Invesco QQQ Trust
QQQ
$463B
| $18M | 13.03% |
115,630
| – | – |
2014 Q4
12 quarters
|
|
3
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.2B
| $16.1M | 11.65% |
46,615
| – | – |
2014 Q4
12 quarters
|
|
4
Apple
AAPL
$4.84T
| $8.19M | 5.92% |
193,592
-660
| -0.3% | -$27.6K |
2014 Q4
12 quarters
|
|
|
5
Johnson & Johnson
JNJ
$641B
| $4.97M | 3.59% |
35,557
-850
| -2% | -$118K |
2014 Q4
12 quarters
|
|
6
iShares Biotechnology ETF
IBB
$11.4B
| $4.55M | 3.29% |
42,585
| – | – |
2015 Q3
9 quarters
|
|
7
iShares MSCI Emerging Markets ETF
EEM
$28.3B
| $3.23M | 2.34% |
68,600
| – | – |
2014 Q4
12 quarters
|
|
8
Berkshire Hathaway Class B
BRK.B
$1.19T
| $3.11M | 2.25% |
15,700
| – | – |
2015 Q4
8 quarters
|
|
9
AbbVie
ABBV
$505B
| $2.96M | 2.14% |
30,580
| – | – |
2014 Q4
12 quarters
|
|
10
Chevron
CVX
$440B
| $2.7M | 1.95% |
21,574
-294
| -1% | -$34.9K |
2014 Q4
12 quarters
|
|
11
Visa
V
$786B
| $2.31M | 1.67% |
20,280
-200
| -1% | -$22.1K |
2014 Q4
12 quarters
|
|
12
Pfizer
PFE
$171B
| $2.16M | 1.56% |
62,884
-685
| -1% | -$23.4K |
2014 Q4
12 quarters
|
|
13
FedEx
FDX
$74.5B
| $2.12M | 1.54% |
8,510
-150
| -2% | -$34.3K |
2014 Q4
12 quarters
|
|
14
UnitedHealth
UNH
$363B
| $1.98M | 1.43% |
8,965
-150
| -2% | -$31.8K |
2015 Q3
9 quarters
|
|
15
Costco
COST
$452B
| $1.87M | 1.36% |
10,065
| – | – |
2017 Q3
1 quarter
|
|
16
Novartis
NVS
$301B
| $1.82M | 1.32% |
24,161
| – | – |
2014 Q4
12 quarters
|
|
17
Zoetis
ZTS
$34.3B
| $1.74M | 1.26% |
24,190
| – | – |
2014 Q4
12 quarters
|
|
18
Blackrock
BLK
$180B
| $1.73M | 1.25% |
3,360
-100
| -3% | -$48.6K |
2014 Q4
12 quarters
|
|
19
Starbucks
SBUX
$119B
| $1.7M | 1.23% |
29,615
| – | – |
2017 Q3
1 quarter
|
|
20
Walt Disney
DIS
$197B
| $1.63M | 1.18% |
15,152
-150
| -1% | -$15.5K |
2016 Q4
4 quarters
|
|
21
Alphabet (Google) Class C
GOOG
$3.42T
| $1.55M | 1.12% |
29,380
| – | – |
2014 Q4
12 quarters
|
|
|
RDS.B
22
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $1.52M | 1.1% |
22,225
| – | – |
2014 Q4
12 quarters
|
|
23
AstraZeneca
AZN
$285B
| $1.3M | 0.94% |
18,700
| – | – |
2015 Q1
11 quarters
|
|
|
24
Target
TGT
$70.1B
| $1.3M | 0.94% |
19,860
+10,960
| +123% | +$662K |
2014 Q4
12 quarters
|
|
25
DELISTED
Hanesbrands
HBI
| $1.27M | 0.92% |
60,695
| – | – |
2016 Q4
4 quarters
|
|
Similar funds
KFA
MGA
MAI
ACM
Daniel Devine & Co's Q4 2017 Portfolio in Review
As of Q4 2017, Daniel Devine & Co held 50 positions worth $138M, up 5.7% from $131M the previous quarter. Its ten largest holdings account for 70% of the portfolio.
Daniel Devine & Co's Q4 2017 filing shows 1 new, 1 increased, 20 reduced and 2 closed positions. The largest sale was GE Aerospace, an estimated $1.85M.
By sector, the portfolio is most concentrated in Miscellaneous at 59% of assets, up from 58% a quarter earlier, followed by Healthcare and Financials.
- Daniel Devine & Co added most to Target in Q4 2017, an estimated $662K increase.
- Daniel Devine & Co's biggest Q4 2017 reduction was State Street Industrial Select Sector SPDR ETF, cutting an estimated $155K.
- Daniel Devine & Co fully exited GE Aerospace in Q4 2017, selling an estimated $1.85M.
- Daniel Devine & Co's ten largest holdings make up 70% of its $138M portfolio in Q4 2017.
- Daniel Devine & Co opened 1 new position and closed 2 in Q4 2017.
- Daniel Devine & Co's portfolio value rose 5.7% quarter-over-quarter to $138M.
Based on Daniel Devine & Co's 13F filing for Q4 2017, filed 24 Jan 2018.